Ausgabe 2/2025 Including Invited Reviews on Advances in preoperative treatment for non-small cell lung cancer
Inhalt (25 Artikel)
PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs; approval of pembrolizumab for locally advanced uterine cervical cancer, and durvalumab and olaparib for advanced or recurrent endometrial cancer in Japan
- PMDA Regulatory Update
Noriomi Matsumura, Masaki Mandai
A prospective study comparing highly qualified Molecular Tumor Boards with AI-powered software as a medical device
- Open Access
- JSCO Board of Directors Series
Hideaki Bando, Yoichi Naito, Tomoyuki Yamada, Takao Fujisawa, Mitsuho Imai, Yasutoshi Sakamoto, Yusuke Saigusa, Kouji Yamamoto, Yutaka Tomioka, Nobuyoshi Takeshita, Kuniko Sunami, Megumi Futamura, Chiemi Notake, Satoko Aoki, Kazunori Okano, Takayuki Yoshino
Transforming cancer screening: the potential of multi-cancer early detection (MCED) technologies
- Open Access
- JSCO Board of Directors Series
Mitsuho Imai, Yoshiaki Nakamura, Takayuki Yoshino
Comprehensive epidemiology of melanoma at all sites: insights from Japan’s National Cancer Registry, 2016–2017
- Cancer Statistics
Dai Ogata, Kenjiro Namikawa, Eiji Nakano, Maiko Fujimori, Yosuke Uchitomi, Takahiro Higashi, Tomoyuki Satake, Chigusa Morizane, Naoya Yamazaki, Akira Kawai
Analysis of lung cancer incidence, mortality trends, and smoking rates in Japan:1975–2022 with insights on the impact of COVID-19
- Cancer Statistics
Hiroki Yamamoto, Masayuki Shirasawa, Katsuhiko Naoki
Postoperative adjuvant therapy with molecularly targeted agents for non-small cell lung cancer
- Invited Review Article
Tomohiro Miyoshi, Masahiro Tsuboi
Adjuvant and neo-adjuvant therapy for non-small cell lung cancer without EGFR mutations or ALK rearrangements
- Invited Review Article
Masaru Takenaka, Koji Kuroda, Fumihiro Tanaka
Treatment strategies for advanced and recurrent endometrial cancer using immune checkpoint inhibitors
- Review Article
Ami Jo, Tadahiro Shoji, Haruka Otsuka, Marina Abe, Shunsuke Tatsuki, Yohei Chiba, Sho Sato, Eriko Takatori, Yoshitaka Kaido, Takayuki Nagasawa, Masahiro Kagabu, Tsukasa Baba
Phase Ib study of the oral PI3Kδ inhibitor linperlisib in patients with advanced solid tumors
- Open Access
- Original Article
Jin Li, Junli Xue, Tianshu Liu, Yi Feng, Nong Xu, Jianjin Huang, Yongmei Yin, Jun Zhang, Haibo Mou, Jiangzhong Shentu, Hanying Bao, Zusheng Xu, Zuhong Xu
Relationship between patient-reported health-related quality of life as measured with the SF-36 or SF-12 and their mortality risk in patients with diverse cancer type: a meta-analysis
- Original Article
Takashi Tanaka, Shinichiro Morishita, Jiro Nakano, Junichiro Inoue, Taro Okayama, Katsuyoshi Suzuki, Keiichi Osaki, Takuya Fukushima
Treatment-related skin reactions in enfortumab vedotin as a surrogate marker of survival and treatment response
- Open Access
- Original Article
Jun Nagayama, Satoshi Inoue, Hiroki Sai, Akira Hayakawa, Yuri Yuguchi, Tomohide Suzuki, Hirotaka Matsui, Takuma Yuba, Koya Morishita, Shusuke Akamatsu
Prediction of prognosis and immune response in lung adenocarcinoma based on mitophagy and lactate-related gene signatures
- Original Article
Wenjie Jiang, Fan Zhang, Zhen Tang, Shuonan Xu, Yukun Zhang, Lina Liu, Daixing Zhong, Yingxiang Liu
Evaluating the impact of atezolizumab on febrile neutropenia occurrence in patients with NSCLC undergoing chemotherapy in Japan: a real-world post-marketing database study
- Open Access
- Original Article
Sayuri Nakane, Akinori Yuri, Yuki Miyano, Kana Yamada, Erika Nakatsuji, Nobuki Takei, Yasuhiro Igarashi, Ryousuke Harada
Discovery and validation of Hsa-microRNA-3665 promoter methylation as a potential biomarker for the prognosis of esophageal squaous cell carcinoma
- Open Access
- Original Article
Jinsong Zhou, Shuang Liu, Juwei Zhang, Qiaoyan Zeng, Zheng Lin, Rong Fu, Yulan Lin, Zhijian Hu
Differences in efficacy of biweekly irinotecan plus cisplatin versus irinotecan alone in second-line treatment of advanced gastric cancer with or without prior gastrectomy
- Original Article
Kazuhiro Nishikawa, Wasaburo Koizumi, Akira Tsuburaya, Motoko Suzuki, Satoshi Morita, Kazumasa Fujitani, Yusuke Akamaru, Ken Shimada, Hisashi Hosaka, Ken Nishimura, Takaki Yoshikawa, Toshimasa Tsujinaka, Junichi Sakamoto
The clinical significance of signal regulatory protein alpha expression in the immune environment of gastric cancer
- Original Article
Yasushi Tanaka, Qingjiang Hu, Tetsuro Kawazoe, Hirotada Tajiri, Ryota Nakanishi, Yoko Zaitsu, Yuichiro Nakashima, Mitsuhiko Ota, Eiji Oki, Yoshinao Oda, Tomoharu Yoshizumi
Effects of aging on complications following robot-assisted radical prostatectomy
- Original Article
Shigeki Koterazawa, Masashi Kubota, Takayuki Sumiyoshi, Ryoichi Saito, Naoto Takaoka, Yuto Hattori, Yosuke Shimizu, Toru Kanno, Takeshi Soda, Yoshiyuki Okada, Kazunari Tsuchihashi, Yuya Sekine, Hiromitsu Negoro, Ryoma Kurahashi, Kimihiro Shimatani, Atsuro Sawada, Shusuke Akamatsu, Takayuki Goto, Takashi Kobayashi
Efficacy of androgen receptor signaling inhibitors in combination with androgen deprivation therapy for castration-sensitive metastatic prostate cancer: a retrospective analysis in a Japanese cohort
- Open Access
- Original Article
Minekatsu Taga, Takeshi Sasaki, Shinichiro Higashi, Shoichi Kimura, Atsuro Sawada, Katsuki Tsuchiyama, Takahiro Inoue, Toshiyuki Kamoto, Naoki Terada
Robotic dual-docking surgery for para-aortic lymphadenectomy in endometrial cancer: a prospective feasibility study
- Open Access
- Original Article
Shintaro Yanazume, Hiroaki Kobayashi, Takashi Ushiwaka, Shinichi Togami, Masaki Kamio
The efficacy and safety of lenvatinib plus pembrolizumab in vulnerable patients with metastatic or recurrent endometrial cancer: a single institution experience
- Original Article
Mayu Yunokawa, Akiko Abe, Xiaofei Wang, Yusuke Toyohara, Ryo Nimura, Takayuki Komoto, Satoki Misaka, Teruyuki Yoshimitsu, Ai Ikki, Mayumi Kamata, Shogo Nishino, Motoko Kanno, Atsushi Fusegi, Sachiho Netsu, Yoichi Aoki, Makiko Omi, Terumi Tanigawa, Sanshiro Okamoto, Hidetaka Nomura, Hiroyuki Kanao
Prospective changes in financial toxicity and health-related quality of life in patients with gynecologic cancer
- Original Article
Kazunori Honda, Yusuke Kajimoto, Shiro Suzuki, Masahiko Mori, Kohshiro Nakao, Anri Azuma, Takashi Shibutani, Shoji Nagao, Takahiro Koyanagi, Izumi Kohara, Shuko Tamaki, Midori Yabuki, Lida Teng, Ataru Igarashi
Efficacy and safety of mosunetuzumab monotherapy for Japanese patients with relapsed/refractory follicular lymphoma: FLMOON-1
- Open Access
- Original Article
Hideki Goto, Takahiro Kumode, Yuko Mishima, Keisuke Kataoka, Yoshiaki Ogawa, Nobuhiro Kanemura, Kazuyuki Shimada, Toshiki Uchida, Yukano Kuroe, Atsuko Kawasaki, Jotaro Sato, Takanori Teshima
Age-related genomic alterations and chemotherapy sensitivity in osteosarcoma: insights from cancer genome profiling analyses
- Open Access
- Original Article
Hidetatsu Outani, Masachika Ikegami, Yoshinori Imura, Sho Nakai, Haruna Takami, Yuki Kotani, Akitomo Inoue, Seiji Okada
Prognostic significance of lymph node metastasis of soft tissue sarcoma of the extremities. National cancer institute experience
- Original Article
Mohamed Shalaby, Rasha M. Allam, Mohamed A. Elkordy, Mohammad Taher
